Tech

BenchSci Announces Two-Year Enterprise Agreement with argenx to Advance AI-Driven Preclinical Drug Discovery

1 source ·1 article ·2h ago

Scientist-led competitive selection deepens BenchSci’s presence in European biopharma TORONTO — BenchSci, a leading provider of AI software for biopharma research and development, today announced a two-year enterprise agreement with argenx,…

Covered by 1 outlet

Financialpost 1

All coverage · 1 article

Financial Post ·2h ago

BenchSci Announces Two-Year Enterprise Agreement with argenx to Advance AI-Driven Preclinical Drug Discovery

BenchSci Announces Two-Year Enterprise Agreement with argenx to Advance AI-Driven Preclinical Drug Discovery →

BenchSci Announces Two-Year Enterprise Agreement with argenx to Advance AI-Driven Preclinical Drug Discovery